Fukuda, Hiromi
Yamaguchi, Daisuke
Nyquist, Kristofor
Yabuki, Yasushi
Miyatake, Satoko
Uchiyama, Yuri
Hamanaka, Kohei
Saida, Ken
Koshimizu, Eriko
Tsuchida, Naomi
Fujita, Atsushi
Mitsuhashi, Satomi
Ohbo, Kazuyuki
Satake, Yuki
Sone, Jun
Doi, Hiroshi
Morihara, Keisuke
Okamoto, Tomoko
Takahashi, Yuji
Wenger, Aaron M.
Shioda, Norifumi
Tanaka, Fumiaki
Matsumoto, Naomichi
Mizuguchi, Takeshi https://orcid.org/0000-0003-4998-1244
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20ek0109425, JP21ek0109486, JP21ek0109549, JP21cm0106503, JP21ek0109493)
Japan Society for the Promotion of Science (JP20K07907, JP21k15097, JP21K06579, JP20K16932, JP21K07869, JP20K17428, JP20K17936, JP19K07977, JP19H03577, JP18K07503, JP20K08164)
MHLW Policy Planning and Evaluation for Rare and Intractable Diseases Program (JPMH19189624)
Takeda Science Foundation
Grant for Strategic Research Promotion from Yokohama City University (#SK2804)
Article History
Received: 1 September 2021
Accepted: 27 October 2021
First Online: 13 November 2021
Declarations
:
: This study was approved by the Institutional Review Board of Yokohama City University School of Medicine. Written informed consent for inclusion in the study was obtained from all participants.
: We have obtained written informed consent for publication of clinical details of the patients.
: K.N. and A.M.W. are employees of Pacific Biosciences.